questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Transferases
Phosphotransferases
Nucleotidyltransferases
RNA nucleotidyltransferases
RNA nucleotidyltransferases : Questions médicales fréquentes
Diagnostic
5
Déficience enzymatique
Tests génétiques
Troubles métaboliques
ARN
Mutations génétiques
Tests génétiques
Symptômes
5
Fatigue
Troubles neurologiques
Troubles métaboliques
Développement anormal
Enfance
Déficience enzymatique
Prévention
5
Prévention
Dépistage génétique
Conseils génétiques
Dépistage prénatal
Éducation
Maladies héréditaires
Dépistage néonatal
Anomalies métaboliques
Traitements
5
Thérapie enzymatique
Suppléments nutritionnels
Thérapie génique
Mutations
Médicaments
Troubles métaboliques
Traitements expérimentaux
Recherche
Changements alimentaires
Nutrition
Complications
5
Complications métaboliques
Complications neurologiques
Réversibilité
Gestion des complications
Maladies associées
Risque accru
Qualité de vie
Complications
Suivi clinique
Évaluations
Facteurs de risque
5
Antécédents familiaux
Mutations génétiques
Âge parental
Risque génétique
Facteurs environnementaux
Risque
Maladies génétiques
Risque
Facteurs nutritionnels
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "RNA nucleotidyltransferases : Questions médicales les plus fréquentes",
"headline": "RNA nucleotidyltransferases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les RNA nucleotidyltransferases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2026-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "RNA nucleotidyltransferases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Nucleotidyltransferases",
"url": "https://questionsmedicales.fr/mesh/D009713",
"about": {
"@type": "MedicalCondition",
"name": "Nucleotidyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D009713",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "DNA-directed RNA polymerases",
"alternateName": "DNA-Directed RNA Polymerases",
"url": "https://questionsmedicales.fr/mesh/D012321",
"about": {
"@type": "MedicalCondition",
"name": "DNA-directed RNA polymerases",
"code": {
"@type": "MedicalCode",
"code": "D012321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.270"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "DNA primase",
"alternateName": "DNA Primase",
"url": "https://questionsmedicales.fr/mesh/D019915",
"about": {
"@type": "MedicalCondition",
"name": "DNA primase",
"code": {
"@type": "MedicalCode",
"code": "D019915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.270.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "RNA polymerase I",
"alternateName": "RNA Polymerase I",
"url": "https://questionsmedicales.fr/mesh/D012318",
"about": {
"@type": "MedicalCondition",
"name": "RNA polymerase I",
"code": {
"@type": "MedicalCode",
"code": "D012318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.270.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "RNA polymerase II",
"alternateName": "RNA Polymerase II",
"url": "https://questionsmedicales.fr/mesh/D012319",
"about": {
"@type": "MedicalCondition",
"name": "RNA polymerase II",
"code": {
"@type": "MedicalCode",
"code": "D012319",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.270.762"
}
}
},
{
"@type": "MedicalWebPage",
"name": "RNA polymerase III",
"alternateName": "RNA Polymerase III",
"url": "https://questionsmedicales.fr/mesh/D012320",
"about": {
"@type": "MedicalCondition",
"name": "RNA polymerase III",
"code": {
"@type": "MedicalCode",
"code": "D012320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.270.775"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Polyribonucleotide nucleotidyltransferase",
"alternateName": "Polyribonucleotide Nucleotidyltransferase",
"url": "https://questionsmedicales.fr/mesh/D011117",
"about": {
"@type": "MedicalCondition",
"name": "Polyribonucleotide nucleotidyltransferase",
"code": {
"@type": "MedicalCode",
"code": "D011117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.532"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Q beta replicase",
"alternateName": "Q beta Replicase",
"url": "https://questionsmedicales.fr/mesh/D011777",
"about": {
"@type": "MedicalCondition",
"name": "Q beta replicase",
"code": {
"@type": "MedicalCode",
"code": "D011777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.630"
}
}
},
{
"@type": "MedicalWebPage",
"name": "RNA helicases",
"alternateName": "RNA Helicases",
"url": "https://questionsmedicales.fr/mesh/D020365",
"about": {
"@type": "MedicalCondition",
"name": "RNA helicases",
"code": {
"@type": "MedicalCode",
"code": "D020365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.720"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "DEAD-box RNA helicases",
"alternateName": "DEAD-box RNA Helicases",
"url": "https://questionsmedicales.fr/mesh/D053487",
"about": {
"@type": "MedicalCondition",
"name": "DEAD-box RNA helicases",
"code": {
"@type": "MedicalCode",
"code": "D053487",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.720.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-58 à domaine DEAD",
"alternateName": "DEAD Box Protein 58",
"url": "https://questionsmedicales.fr/mesh/D000071457",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-58 à domaine DEAD",
"code": {
"@type": "MedicalCode",
"code": "D000071457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.720.249.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéine-58 à domaine DEAD",
"alternateName": "DEAD Box Protein 58",
"url": "https://questionsmedicales.fr/mesh/D000071457",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-58 à domaine DEAD",
"code": {
"@type": "MedicalCode",
"code": "D000071457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.720.249.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "RNA replicase",
"alternateName": "RNA-Dependent RNA Polymerase",
"url": "https://questionsmedicales.fr/mesh/D012324",
"about": {
"@type": "MedicalCondition",
"name": "RNA replicase",
"code": {
"@type": "MedicalCode",
"code": "D012324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.696.445.735.780"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "RNA nucleotidyltransferases",
"alternateName": "RNA Nucleotidyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D012316",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ben Usher",
"url": "https://questionsmedicales.fr/author/Ben%20Usher",
"affiliation": {
"@type": "Organization",
"name": "Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK."
}
},
{
"@type": "Person",
"name": "Pierre Genevaux",
"url": "https://questionsmedicales.fr/author/Pierre%20Genevaux",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire de Microbiologie et Génétique Moléculaires, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 118 route de Narbonne, 31400 Toulouse, France."
}
},
{
"@type": "Person",
"name": "Tim R Blower",
"url": "https://questionsmedicales.fr/author/Tim%20R%20Blower",
"affiliation": {
"@type": "Organization",
"name": "Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK."
}
},
{
"@type": "Person",
"name": "Junwan Lu",
"url": "https://questionsmedicales.fr/author/Junwan%20Lu",
"affiliation": {
"@type": "Organization",
"name": "Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, China."
}
},
{
"@type": "Person",
"name": "Qiyu Bao",
"url": "https://questionsmedicales.fr/author/Qiyu%20Bao",
"affiliation": {
"@type": "Organization",
"name": "Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Activation of human RNA lariat debranching enzyme Dbr1 by binding protein TTDN1 occurs though an intrinsically disordered C-terminal domain.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37507019",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.105100"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expanding the available RNA labeling toolbox with CutA nucleotidyltransferase for efficient transcript labeling with purine and pyrimidine nucleotide analogs.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38818670",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cbic.202400202"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inducible auto-phosphorylation regulates a widespread family of nucleotidyltransferase toxins.",
"datePublished": "2024-09-04",
"url": "https://questionsmedicales.fr/article/39231966",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-51934-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Substrate specificity of Mycobacterium tuberculosis tRNA terminal nucleotidyltransferase toxin MenT3.",
"datePublished": "2024-03-15",
"url": "https://questionsmedicales.fr/article/38485701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/nar/gkae177"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mRNA-capping enzyme localizes to stress granules in the cytoplasm and maintains cap homeostasis of target mRNAs.",
"datePublished": "2024-06-06",
"url": "https://questionsmedicales.fr/article/38841902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/jcs.261578"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transferases",
"item": "https://questionsmedicales.fr/mesh/D014166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Phosphotransferases",
"item": "https://questionsmedicales.fr/mesh/D010770"
},
{
"@type": "ListItem",
"position": 6,
"name": "Nucleotidyltransferases",
"item": "https://questionsmedicales.fr/mesh/D009713"
},
{
"@type": "ListItem",
"position": 7,
"name": "RNA nucleotidyltransferases",
"item": "https://questionsmedicales.fr/mesh/D012316"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : RNA nucleotidyltransferases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur RNA nucleotidyltransferases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur RNA nucleotidyltransferases",
"description": "Comment diagnostiquer une déficience en nucleotidyltransferases ?\nQuels tests sont utilisés pour évaluer l'activité des RNA nucleotidyltransferases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec ces enzymes ?\nPeut-on détecter des mutations génétiques liées à ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur RNA nucleotidyltransferases",
"description": "Quels symptômes sont associés à une dysfonction des RNA nucleotidyltransferases ?\nLes symptômes varient-ils selon le type d'enzyme affectée ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils réversibles avec un traitement ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur RNA nucleotidyltransferases",
"description": "Peut-on prévenir les déficiences en nucleotidyltransferases ?\nY a-t-il des mesures préventives pour les familles à risque ?\nL'éducation sur les maladies héréditaires est-elle importante ?\nLes vaccinations peuvent-elles jouer un rôle préventif ?\nLes tests de dépistage néonatal sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur RNA nucleotidyltransferases",
"description": "Quels traitements sont disponibles pour les déficiences en nucleotidyltransferases ?\nLa thérapie génique est-elle une option de traitement ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nY a-t-il des traitements expérimentaux en cours ?\nLes changements alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur RNA nucleotidyltransferases",
"description": "Quelles complications peuvent survenir avec ces déficiences ?\nLes complications sont-elles réversibles ?\nY a-t-il un risque accru de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur RNA nucleotidyltransferases",
"description": "Quels sont les facteurs de risque pour les déficiences en nucleotidyltransferases ?\nL'âge parental influence-t-il le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLes maladies génétiques augmentent-elles le risque ?\nLes facteurs nutritionnels influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D012316#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en nucleotidyltransferases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des RNA nucleotidyltransferases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurant l'incorporation de nucléotides dans l'ARN sont utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais elles peuvent être utiles pour des analyses plus approfondies."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec ces enzymes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la synthèse d'ARN, pouvant entraîner des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations génétiques liées à ces enzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant leur fonction."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une dysfonction des RNA nucleotidyltransferases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de croissance, et anomalies neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'enzyme affectée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types d'enzymes peuvent entraîner des symptômes variés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les signes de troubles métaboliques et de développement anormal."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître dès l'enfance, selon la gravité de la déficience enzymatique."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles avec un traitement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la nature de la déficience, certains peuvent être réversibles."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les déficiences en nucleotidyltransferases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage génétique peut aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les familles à risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conseils génétiques et le dépistage prénatal peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "L'éducation sur les maladies héréditaires est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation aide les familles à comprendre les risques et les options disponibles."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle préventif ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne sont pas directement liées à la prévention des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage néonatal sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent détecter certaines anomalies métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déficiences en nucleotidyltransferases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des thérapies enzymatiques et des suppléments nutritionnels."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée comme une option pour corriger les mutations."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à gérer les symptômes associés aux troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux en cours ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches sont en cours pour développer de nouveaux traitements ciblés."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des modifications alimentaires peuvent être bénéfiques pour certains patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces déficiences ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications métaboliques, neurologiques et de croissance peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être à risque accru de maladies métaboliques et neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers et des évaluations cliniques sont essentiels pour la surveillance."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déficiences en nucleotidyltransferases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge parental influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé des parents peut augmenter le risque de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions environnementales peuvent influencer le risque de déficiences."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies génétiques héréditaires peuvent augmenter le risque de déficiences."
}
},
{
"@type": "Question",
"name": "Les facteurs nutritionnels influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition inadéquate peut exacerber les symptômes chez les individus à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK.
Publications dans "RNA nucleotidyltransferases" :
3 publications dans cette catégorie
Affiliations :
Laboratoire de Microbiologie et Génétique Moléculaires, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 118 route de Narbonne, 31400 Toulouse, France.
Publications dans "RNA nucleotidyltransferases" :
3 publications dans cette catégorie
Affiliations :
Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK.
Publications dans "RNA nucleotidyltransferases" :
3 publications dans cette catégorie
Affiliations :
Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, China.
Publications dans "RNA nucleotidyltransferases" :
3 publications dans cette catégorie
Affiliations :
Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, China.
Publications dans "RNA nucleotidyltransferases" :
3 publications dans cette catégorie
Affiliations :
The Salk Institute, La Jolla, CA 92037.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of RNA Biology, International Institute of Molecular and Cell Biology, Warsaw, Poland.
Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 205 route de Narbonne, 31400 Toulouse, France.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 205 route de Narbonne, 31400 Toulouse, France.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Rna Biology, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Faculty of Biology, Institute of Genetics and Biotechnology, University of Warsaw, Warsaw, Poland.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Centre of New Technologies, University of Warsaw, Warsaw, Poland.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Biosciences, Durham University, Durham, UK.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, New York University, New York, New York 10003, United States.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, New York University, New York, New York 10003, United States.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, China, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Children's Respiration Disease, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Institute of Biomedical Informatics, Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Publications dans "RNA nucleotidyltransferases" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, China.
Publications dans "RNA nucleotidyltransferases" :
In eukaryotic cells, the introns are excised from pre-mRNA by the spliceosome. These introns typically have a lariat configuration due to the 2'-5' phosphodiester bond between an internal branched res...
RNA labeling is an invaluable tool for investigation of the function and localization of nucleic acids. Labels are commonly incorporated into 3' end of RNA and the primary enzyme used for this purpose...
Nucleotidyltransferases (NTases) control diverse physiological processes, including RNA modification, DNA replication and repair, and antibiotic resistance. The Mycobacterium tuberculosis NTase toxin ...
Mycobacterium tuberculosis transfer RNA (tRNA) terminal nucleotidyltransferase toxin, MenT3, incorporates nucleotides at the 3'-CCA end of tRNAs, blocking their aminoacylation and inhibiting protein s...
The model of RNA stability has undergone a transformative shift with the revelation of a cytoplasmic capping activity that means a subset of transcripts are recapped autonomously of their nuclear coun...
RNA surveillance systems degrade aberrant RNAs that result from defective transcriptional termination, splicing, and polyadenylation. Defective RNAs in the nucleus are recognized by RNA-binding protei...
In reference to gene annotation, more than half of the tRNA species synthesized by Mycobacterium tuberculosis require the enzymatic addition of the cytosine-cytosine-adenine (CCA) tail, which is indis...
The majority of genic transcription is intronic. Introns are removed by splicing as branched lariat RNAs which require rapid recycling. The branch site is recognized during splicing catalysis and late...
Many polymerases and other proteins are endowed with a catalytic domain belonging to the nucleotidyltransferase fold, which has also been deemed the non-canonical palm domain, in which three conserved...
Purine-containing nucleotide second messengers regulate diverse cellular activities. Cyclic di-pyrimidines mediate anti-phage functions in bacteria; however, the synthesis mechanism remains elusive. H...